AstraZeneca PLC (NASDAQ:AZN)
| 53.80 Delayed Data As of May 07 |  +0.32 / +0.60%Today’s Change | 46.48 Today|||52-Week Range 64.94 | +7.62% Year-to-Date |
Latest AZN News | Press Releases
| 4 Reasons to Hang On to Your Moderna Stock May 08 / MotleyFool.com - Paid Partner Content | Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market? May 07 / MotleyFool.com - Paid Partner Content |
| Could AstraZeneca and Sanofi Win Big in RSV? May 08 / MotleyFool.com - Paid Partner Content | Why is the EU Suing AstraZeneca? May 06 / MotleyFool.com - Paid Partner Content |
| Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines May 07 / Zacks.com - Paid Partner Content | Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates May 05 / Zacks.com - Paid Partner Content |
| Ironwood's (IRWD) Q1 Earnings Beat, 2021 Guidance Muted May 07 / Zacks.com - Paid Partner Content | Should Pfizer and Moderna Be Worried About This New COVID Vaccine Study? May 05 / MotleyFool.com - Paid Partner Content |
| Moderna (MRNA) Beats on Q1 Earnings, Ups Vaccine Sales View May 07 / Zacks.com - Paid Partner Content | Why Emergent BioSolutions Stock Dropped 30% in April May 04 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 53.48 |
| Today’s open | 53.53 |
| Day’s range | 53.53 - 54.05 |
| Volume | 556,635 |
| Average volume (3 months) | 10,915,170 |
| Market cap | $141.3B |
Data as of 4:00pm ET, 05/07/2021
Growth & Valuation
| Earnings growth (last year) | +138.26% |
| Earnings growth (this year) | +32.10% |
| Earnings growth (next 5 years) | +19.00% |
| Revenue growth (last year) | +13.57% |
| P/E ratio | 35.5 |
| Price/Sales | 4.72 |
| Price/Book | 9.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | -0.02 | -0.03% |
| NVONovo Nordisk | +1.50 | +2.02% |
| SNYSanofi | +0.82 | +1.61% |
| GSKGlaxoSmithKline | +0.44 | +1.15% |
Data as of 4:00pm ET, 05/07/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $27.8B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 11.58% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
